Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

SMS Pharmaceuticals Ltd - 532815 - COMPLIANCE CERTIFICATE UNDER REGULATION 7(3) OF THE SEBI

 1. We the undersigned, hereby certify that all activities pertaining to transfer of equity shares both in physical and electronic form of the SMS Pharmaceuticals Limited for the period from 1st October, 2020 to 31st March, 2021 has been maintained by the Registrar & Share Transfer Agent (RTA & STA) M/s. AARTHI CONSULTANTS PRIVATE LIMITED (SEBI registration number INR000000379), having office at 1-2-285, Domalguda, Hyderabad, Telangana-500029 in effective and efficient manner. 2. This Certificate is issued in pursuance of Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and should not be used for any other purpose. Please take the above mentioned on your records.
26-04-2021
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 we are forwarding herewith a copy of the Certificate dated 7th April, 2021, received from Aarthi Consultants Private Limited, Hyderabad, the Registrar and Share Transfer Agent of the Company for the quarter ended 31st March, 2021.
24-04-2021
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Statement Under Regulation 40(9)&(10) For The Half Year Ended On 31St March, 2021

 Pursuant to the Regulation 40(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are submitting herewith a Compliance certificate issued by Mr. C. Sudhir Babu, practicing company secretary for the half year ended 31st March, 2021.
24-04-2021
Bigul

SMS Pharmaceuticals Ltd - 532815 - Shareholding for the Period Ended March 31, 2021

 SMS Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
19-04-2021
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Statement Of Investor Complaints For The Quarter Ended March 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- RAMESH BAB POTLURIDesignation :- Managing Director / Whole Time Director
19-04-2021
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Closure of Trading Window

 This is to inform you that the Trading Window for dealing in securities of the Company by Directors, Promoters, Designated Employees and Specified Connected Persons of the Company and associated of the Company shall remain closed with effect from 1st April, 2021 till conclusion of 48 hours after the declaration of Audited Financial Results of the Company for the quarter and year ended on 31st March, 2021.
30-03-2021
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Publishing of Financial Results in Newspaper Regulation 47(1)(b) of SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015 Further to our intimation dated 10th February, 2021, please find the enclosed herewith copies of the newspaper advertisements published on 11th February, 2021, regarding financial results for quarter and nine months ended as on 31st December, 2020. Please that this information is published within 48 hours of closure of the Board Meeting as specified in Regulation 47(3) of SEBI (Listing obligations & Disclosure Requirements) regulations, 2015. Kindly take the above information on record
12-02-2021
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Outcome Of Board Meeting Held On 10Th February, 2021

 1. The Standalone and consolidated Un-audited Financial Results for the third Quarter and Nine months ended 31st December, 2020 along with the Limited Review Report. 2. Please refer to our earlier communication with regarding to floating of Joint Venture (JV) with Chemo, we glad to inform you that the JV has been incorporated in Spain with nomenclature of 'CHEMO SMS ENTERPRISES SL' in the ratio of 55:45 and we are securing the share of 45%. The objective of the JV has been setup to develop the products and manufacturing them at our manufacturing facility. The technical ownership of the JV products will be the property of the JV Company which includes Drug Mater Filings (DMFs) of the Products under JV.
10-02-2021
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 - Advertisement in News Paper. With reference to subject cited above we are herewith enclosing the copies of advertisement issued in newspapers on 4th February, 2021 in 'Financial Express' in English language and in 'Andhra Prabha' in Telugu Language, with respect to intimation of Board Meeting for considering Un-audited financial results for the third quarter ended 31st December, 2020.
06-02-2021
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Intimation for Notice Of Board Meeting To Be Held On 10.02.2021

 SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2021 ,inter alia, to consider and approve NOTICE is hereby given pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Sec. 173 of the Companies Act, 2013 that a meeting of the Board of Directors of the Company will be held on the Wednesday, 10th day of February, 2021, at the Registered Office of the Company, inter alia, for the following items: To consider and approve the Un-audited Standalone and Consolidated Financial results of the Company for the third quarter ended as on 31st December, 2020. Please be informed that Insider Trading window of SMS Pharmaceuticals Limited shall remain closed till 12th February, 2021 in view of the above mentioned Board Meeting.
03-02-2021
Next Page
Close

Let's Open Free Demat Account